GENELUX CORPORATION (GNLX) ROE
- 2026-06-30: ROE -220.91%.
- 2026-03-31: ROE -146.51%.
- 2025-12-31: ROE -278.46%.
- 2025-09-30: ROE -171.45%.
Complete source-backed roe history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -220.91% |
| 2026-03-31 | -146.51% |
| 2025-12-31 | -278.46% |
| 2025-09-30 | -171.45% |
| 2025-06-30 | -127.17% |
| 2025-03-31 | -98.88% |
| 2024-12-31 | -113.68% |
| 2024-09-30 | -83.59% |
| 2024-06-30 | -70.45% |
| 2024-03-31 | -170.93% |
| 2023-12-31 | -145.31% |
| 2023-09-30 | -104.15% |
| 2023-06-30 | -66.37% |
| 2023-03-31 | -437.38% |
| 2022-12-31 | 14.55% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -278.46% |
| 2024-12-31 | -113.68% |
| 2023-12-31 | -145.31% |
| 2022-12-31 | 14.55% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |